2024 EMNLP EMNLP 2024

Language Models are Surprisingly Fragile to Drug Names in Biomedical Benchmarks

Abstract

AbstractMedical knowledge is context-dependent and requires consistent reasoning across various natural language expressions of semantically equivalent phrases. This is particularly crucial for drug names, where patients often use brand names like Advil or Tylenol instead of their generic equivalents. To study this, we create a new robustness dataset, RABBITS, to evaluate performance differences on medical benchmarks after swapping brand and generic drug names using physician expert annotations.We assess both open-source and API-based LLMs on MedQA and MedMCQA, revealing a consistent performance drop ranging from 1-10%. Furthermore, we identify a potential source of this fragility as the contamination of test data in widely used pre-training datasets.

🌉 Interdisciplinary Bridge — Deep Learning and Healthcare & Medicine and Machine Learning and Natural Language Processing
🧭 Keyword Pioneer — biomedical benchmark
🐝 Cross-Pollinator — Artificial Intelligence, Computer Science, Computer Vision, Data Science & Analytics, Deep Learning, Healthcare & Medicine, Interdisciplinary, Knowledge & Reasoning, Machine Learning, Mathematics & Optimization, Natural Language Processing, Reinforcement Learning, Robotics, Security & Privacy, Speech & Audio